Akihisa Hino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Akihisa Hino has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Kentaro Fukushima
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
3 shared publications Naoki Hosen
Department of Haematology and Oncology, The University of Osaka Graduate School of Medicine, Suita, Japan
3 shared publicationsJiro Fujita
Department of Haematology and Oncology, The University of Osaka Graduate School of Medicine, Suita, Japan
2 shared publications- Shinsuke Kusakabe
Department of Hematology and Oncology, The University of Osaka Hospital, Osaka, Japan
2 shared publications Tomoaki Ueda
Department of Haematology and Oncology, The University of Osaka Graduate School of Medicine, Suita, Japan
2 shared publicationsAtsushi Hayashi
R&D Division, Central Research Institute Miyarisan Pharmaceutical Co. Ltd. Saitama Japan
1 shared publication
Latest Publications
- 3 October 2026
- Published by Springer Nature in International Journal of Hematology
- p. 1-10
Potential clinical benefits of early belumosudil treatment in chronic graft-versus-host disease
- 3 October 2026
- Published by Springer Nature in International Journal of Hematology
- p. 1-10
Potential clinical benefits of early belumosudil treatment in chronic graft-versus-host disease
- Open Access
- 7 September 2025
- Published by Wiley in British Journal of Haematology
- Vol. 207 (5) , 2187-2191
Enterococcus proliferates via the phosphotransferase system in the disrupted gut microbiota after allogeneic haematopoietic stem cell transplantation
- 7 September 2025
- Published by Wiley in British Journal of Haematology
- Vol. 207 (5) , 2187-2191
Open AccessEnterococcus proliferates via the phosphotransferase system in the disrupted gut microbiota after allogeneic haematopoietic stem cell transplantation
- 5 December 2022
- Published by Wiley in British Journal of Haematology
- Vol. 201 (4) , 725-737
Prolonged gut microbial alterations in post‐transplant survivors of allogeneic haematopoietic stem cell transplantation
Summary: Dysbiosis of the gut microbiota has been reported to increase early complications after allogeneic haematopoietic stem cell transplantation (allo‐HSCT). However, it remains unclear whether gut microbial alterations persist during late complications, such as chronic graft‐versus‐host disease (cGVHD) or secondary cancers. Here, we analysed the gut microbiota of 59 patients who survived for 1–21.7 years (median, 6.4 years) after allo‐HSCT. Long‐term survivors showed lower gut microbial diversity than the age‐ and sex‐matched healthy controls. This decreased diversity was reflected in the reduced abundance of the butyrate‐producing bacteria. Patients with a history of grade 3 acute graft‐versus‐host disease (aGVHD) exhibited higher Veillonella abundance than patients with a history of grade 1–2 or non‐aGVHD cases. The abundance of Faecalibacterium showed no decrease only in limited cGVHD cases. Additionally, the microbial structure in the secondary cancer group was significantly different (p < 0.05) from that in the non‐secondary cancer group. This study is the first to show that microbial dysbiosis is present over a 10‐year lifetime after discharge following allo‐HSCT. Our results suggest that these prolonged gut microbial alterations may be associated with the development and exacerbation of late complications in post‐transplant survivors.
- 5 December 2022
- Published by Wiley in British Journal of Haematology
- Vol. 201 (4) , 725-737
Prolonged gut microbial alterations in post‐transplant survivors of allogeneic haematopoietic stem cell transplantation
Summary: Dysbiosis of the gut microbiota has been reported to increase early complications after allogeneic haematopoietic stem cell transplantation (allo‐HSCT). However, it remains unclear whether gut microbial alterations persist during late complications, such as chronic graft‐versus‐host disease (cGVHD) or secondary cancers. Here, we analysed the gut microbiota of 59 patients who survived for 1–21.7 years (median, 6.4 years) after allo‐HSCT. Long‐term survivors showed lower gut microbial diversity than the age‐ and sex‐matched healthy controls. This decreased diversity was reflected in the reduced abundance of the butyrate‐producing bacteria. Patients with a history of grade 3 acute graft‐versus‐host disease (aGVHD) exhibited higher Veillonella abundance than patients with a history of grade 1–2 or non‐aGVHD cases. The abundance of Faecalibacterium showed no decrease only in limited cGVHD cases. Additionally, the microbial structure in the secondary cancer group was significantly different (p < 0.05) from that in the non‐secondary cancer group. This study is the first to show that microbial dysbiosis is present over a 10‐year lifetime after discharge following allo‐HSCT. Our results suggest that these prolonged gut microbial alterations may be associated with the development and exacerbation of late complications in post‐transplant survivors.